|
?:abstract
|
-
Background: On March 11, 2020, the World Health Organization (WHO) officially declared coronavirus disease 2019 a global pandemic Ivermectin and Doxycycline against SARSCoV-2 under in-vitro conditions showed beneficial results However, large population studies with this combination are not elaborately studied, which was the aim of our study Materials and methods: A total of 122 patients admitted in a tertiary care centre, who tested positive for Reverse-transcriptase-polymerase-chain-reaction (RT-PCR) for SARS-CoV2 were included in the study and a total sample size of 100 patients was obtained after exclusion 50 patients of the treatment group were treated with Ivermectin-Doxycycline combination Results: The results had shown a significant reduction not only in mean duration of hospital (3 70 ± 2 27 days vs 4 69 ± 2 3 days), but also in complete resolution of symptoms stay (6 67 ± 2 01 days vs 4 69 ± 2 3 days) In a small subset of 10 patients RT-PCR for COVID was tested on 10th day after the symptom onset in both the groups and there was no difference to be found There was no significant difference in the side effect profile of either groups Conclusion: Our study supports the benefits of utilization of combination of Doxycycline and Ivermectin in mild to moderate COVID-19 infection in terms of early recovery based on the time for symptom resolution and the mean duration of hospital stay [ABSTRACT FROM AUTHOR] Copyright of International Archives of Integrated Medicine is the property of International Archives of Integrated Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder\'s express written permission However, users may print, download, or email articles for individual use This abstract may be abridged No warranty is given about the accuracy of the copy Users should refer to the original published version of the material for the full abstract (Copyright applies to all Abstracts )
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}